HHQ16

Revisión del cliente

Based on 1 Customer Validation

HHQ16 is an orally active derivative of Astragaloside IV (HY-N0431). HHQ16 effectively reverses infarction-induced hypertrophy and heart failure by targeted degrading lnc4012/lnc9456 and antagonizing their effects on G3BP2/NF-κB signaling.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza: 99.97%
  • No. CAS: 2620471-66-9
  • Fòrmula: C30H48F2O4
  • Peso molecular:510.70
  • Almacenamiento:

    4°C, sealed storage, away from moisture

    * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

  • Actividad biológica
  • Chemical Information
  • Solvente y solubilidad
  • Pureza y Documentación
  • Referencias
  • Help & FAQs
100 mg

Obtener un presupuesto En stock

Please select quantity
Amount: USD 0.00